gms | German Medical Science

62nd Annual Meeting of the German Society of Neurosurgery (DGNC)
Joint Meeting with the Polish Society of Neurosurgeons (PNCH)

German Society of Neurosurgery (DGNC)

7 - 11 May 2011, Hamburg

Prevalence of InfinOH-Subgroup (Infratentorial Intracisternal Obstructive Hydrocephalus) in idiopathic normal pressure hydrocephalus patients

Meeting Abstract

Search Medline for

  • U. Kehler - Neurosurgical Department, Asklepios Klinik Altona, Hamburg, Germany
  • J. Herzog - Neurosurgical Department, Asklepios Klinik Altona, Hamburg, Germany

Deutsche Gesellschaft für Neurochirurgie. Polnische Gesellschaft für Neurochirurgen. 62. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC), Joint Meeting mit der Polnischen Gesellschaft für Neurochirurgen (PNCH). Hamburg, 07.-11.05.2011. Düsseldorf: German Medical Science GMS Publishing House; 2011. DocMO.03.05

doi: 10.3205/11dgnc005, urn:nbn:de:0183-11dgnc0050

Published: April 28, 2011

© 2011 Kehler et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



Objective: InfinOH is a communicating hydrocephalus with infratentorial intracisternal CSF-pathway obstruction, which can be treated successfully by endoscopic third ventriculostomy (ETV). The reported success-rate is around 70%. Various cases are found among patients with idiopathic normal pressure hydrocephalus (iNPH), but the frequency is unknown. Undetected InfinOHs in NPH patients means unnecessary shunt surgeries were ETV would be an alternative with similar results but less complications and less costs. A MRI-analysis of all iNPH-patients is necessary to find out the prevalence of InfinOHs and to assess the importance of differentiating "normal" iNPH and InfinOH.

Methods: Between August 2005 and June 2009 165 idiopathic NPH patients were treated. In all cases additional high resolution mid sagittal T2 weighted MRI scans were performed and analyzed for InfinOH: Diagnosis was confirmed, when the aqueduct and the fourth ventricle outflows were patent and the floor of the 3rd ventricle bulged downward simultaneously as well as the lamina terminalis pushed forward.

Results: From the 165 NPH patients treated surgically, 21 patients with clinical signs of iNPH showed the MRI-criteria of InfInOH corresponding 12,7%. The mean age of InfinOH patients were 56,7 years (range: 35–76 years) versus 72,2 years (range: 25–87 years) in the remaining iNPH patients. All InfinOH-patients were treated with ETV, all other pat. were treated with vp-shunts.

Conclusions: InfinOH is not frequently found in iNPH patients (12,7%). However, to neglect this subgroup means almost 13% of patients would be treated with a suboptimal vp-shunt instead of ETV accepting more complications all over. Focusing our attention to InfinOH could help to improve patients' selection for ETV or shunt, could reduce complications and costs.